Mice treated with doxorubicin alone or combination treatment had lower expression of tumor PD-L1, CTLA-4, Foxp3, and tumor-infiltrating dendritic cell (CD86) proteins than did controls, with the lowest expression in mice co-treated with high-FO/Se (Figures 5B, 5C). This evidence concerns the gene CTLA4 and neoplasm.